CDKN1A and Familial prostate cancer: Lately, Pao-Hsuan Huang and colleagues reported CDK5 could directly target p21, and overexpression of CDK5 triggered the degradation of p21 and promoted several cancer cells (breast cancer, prostate cancer, lung cancer) growth [24].